Maps Laboratories is an API manufacturer based in India. It holds 2 valid CEPs across a filed portfolio of 3 molecules. Its GMP standing is certified by CDSCO (India). Customs aggregates show $1.5M of exports covering 72 molecules to 14 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Rafaleshwar, India | Not on file |
| tal morbi jambudia 363 642 rajkot, India | Not on file |
| rajkot, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Levocetirizine Dihydrochloride | SFDA (Saudi Arabia) | 1 |
| Pregabalin | EDQM | 1 |
| Trimetazidine Dihydrochloride | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | None | 3 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $136K | 8 |
| 2025 | Not reported | $1.5M | 14 |
| 2024 | Not reported | $876K | 12 |
| 2023 | Not reported | $1.9M | 17 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Maps Laboratories comes back tiered against every other supplier able to file there.
Start for free